Inactive Instrument

News Hemostemix Inc Toronto S.E.

Equities

CA4236941080

Summary

Unlock all the news: Be the first to know and act before the market!

Hemostemix Announces Trademark Granted by Switzerland and Interest Payment	Jun. 11	NE
Hemostemix Announces Strategic Manufacturing Partnership with Cytoimmune Therapuetics	Jun. 10	CI
Hemostemix Announces Strategic Manufacturing Partnership with CytoImmune Therapeutics and $1,800,000 in Financing Commitments	Jun. 03	NE
Hemostemix Inc. announced that it expects to receive CAD 2 million in funding	Jun. 02	CI
Hemostemix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 30	CI
Hemostemix Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
Hemostemix Announces Engagement of Oak Hill Asset Management Inc.	Mar. 07	NE
Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences	Feb. 06	CI
Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences	Feb. 06	NE
Hemostemix Clarifies its October 3, 2023 News Release	Dec. 29	NE
Hemostemix Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29	CI
Hemostemix Inc. Announces That 4Th Heart Study Published in Stem Cell Research & Therapy Confirms Treatment for Heart Disease	23-10-31	CI
Hemostemix's 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart Disease	23-10-30	NE
Hemostemix Announces Amendment of its $2.5 Million 5 Year Convertible Debenture Issued on June 11, 2021, Resulting in an Expected Interest Saving of Approximately $570,000	23-10-23	NE
Hemostemix Closed Private Placement	23-10-03	MT
Hemostemix Closed $320,125 Private Placement	23-10-03	NE
Hemostemix Inc. announced that it has received CAD 0.320385 million in funding	23-10-02	CI
Hemostemix Inc. announced that it expects to receive CAD 0.325125 million in funding	23-09-27	CI
Hemostemix Announces Private Placement	23-09-27	NE
Hemostemix Inc. announced that it has received CAD 0.72754 million in funding	23-09-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hemostemix Inc Toronto S.E.

Equities

CA4236941080

Summary

Filters